Trial Profile
Safety and efficacy of botulinum toxin A in patients with craniocervical dystonia and hemifacial spasm
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dystonia; Hemifacial spasm
- Focus Adverse reactions; Therapeutic Use
- 26 Sep 2016 New trial record